Sign in
Inflammatory and Infectious Diseases Symposium
Annual Meeting Talks
2020
GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results
Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022
Controlling Uveitic Recurrences: Results From a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Insert (FAi) in Noninfectious Posterior Uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
2018
Category: Inflammatory and Infectious Diseases- White Dot Syndromes